AviaraDx’s diagnostic tests can be used in the molecular classification of cancers and to assist oncologists in making therapeutic decisions.
Aviara CancerType ID provides improved cancer classification, especially for patients diagnosed with metastatic cancer where the origin is uncertain or unknown.
Aviara Breast Cancer Index offers a combined assessment of two Aviara markers (H/l and MGI) for risk prognosis and treatment response prediction for chemo- and hormonal therapy.
Phone: 1800 333 421
Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium
The products provide researchers and manufacturers with high-performance, scalable and...
Grace Bio-Labs protein microarray tools
Grace Bio-Labs' microarray substrates provide high binding capacity and enable high assay...
Siemens Healthineers 3gAllergy assay
Siemens Healthineers has expanded its 3gAllergy assay menu with nine additional component...
